Lambert AA, Dransfield MT. COPD overlap syndromes: asthma and beyond. Chronic Obstr Pulm Dis. 2016;3(1):459–65. https://doi.org/10.15326/jcopdf.3.1.2015.0176.
Article
PubMed
PubMed Central
Google Scholar
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–94. https://doi.org/10.1016/S0025-6196(11)60735-0.
Article
PubMed
Google Scholar
Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, et al. A Japanese lung Cancer registry study: prognosis of 13,010 resected lung cancers. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2008;3(1):46–52. https://doi.org/10.1097/JTO.0b013e31815e8577.
Article
Google Scholar
Albain KS, Swann RS, Rusch VW, Turrisi AT, 3rd, Shepherd FA, Smith C, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet (London, England). 2009;374(9687):379–386.
Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and leukemia group B, radiation therapy oncology group, and north central Cancer treatment group study groups. J Clin Oncol. 2008;26(31):5043–51. https://doi.org/10.1200/JCO.2008.16.4855.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J Clin Oncol. 2008;26(21):3552–9. https://doi.org/10.1200/JCO.2007.13.9030.
Article
PubMed
Google Scholar
Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, Le Chevalier T, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet (London, England). 2010;375(9722):1267–1277.
Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, et al. Demographics, safety and quality, and prognostic information in both the seventh and eighth editions of the TNM classification in 18,973 surgical cases of the Japanese joint Committee of Lung Cancer Registry Database in 2010. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2019;14(2):212–22. https://doi.org/10.1016/j.jtho.2018.10.002.
Article
Google Scholar
Scagliotti GV, Fossati R, Torri V, Crinò L, Giaccone G, Silvano G, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst. 2003;95(19):1453–61. https://doi.org/10.1093/jnci/djg059.
Article
CAS
PubMed
Google Scholar
Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(2):409–417; discussioin 17–8.
Nesbitt JC, Putnam JB Jr, Walsh GL, Roth JA, Mountain CF. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg. 1995;60(2):466–72. https://doi.org/10.1016/0003-4975(95)00169-L.
Article
CAS
PubMed
Google Scholar
Hamanaka R, Yokose T, Sakuma Y, Tsuboi M, Ito H, Nakayama H, et al. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer. Diagn Pathol. 2015;10(1):17. https://doi.org/10.1186/s13000-015-0249-5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Luo X, Zang X, Yang L, Huang J, Liang F, Rodriguez-Canales J, et al. Comprehensive computational pathological image analysis predicts lung Cancer prognosis. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017;12(3):501–9. https://doi.org/10.1016/j.jtho.2016.10.017.
Article
Google Scholar
Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012;279(15):2610–23. https://doi.org/10.1111/j.1742-4658.2012.08644.x.
Article
CAS
PubMed
Google Scholar
Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis. 2016;5(1):e189. https://doi.org/10.1038/oncsis.2015.49.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hosokawa Y, Masaki N, Takei S, Horikawa M, Matsushita S, Sugiyama E, et al. Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues. PLoS One. 2017;12(8):e0183724. https://doi.org/10.1371/journal.pone.0183724.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tamura K, Horikawa M, Sato S, Miyake H, Setou M. Discovery of lipid biomarkers correlated with disease progression in clear cell renal cell carcinoma using desorption electrospray ionization imaging mass spectrometry. Oncotarget. 2019;10(18):1688–703. https://doi.org/10.18632/oncotarget.26706.
Article
PubMed
PubMed Central
Google Scholar
Takanashi Y, Funai K, Sato S, Kawase A, Tao H, Takahashi Y, et al. Sphingomyelin(d35:1) as a novel predictor for lung adenocarcinoma recurrence after a radical surgery: a case-control study. BMC Cancer. 2020;20(1):800. https://doi.org/10.1186/s12885-020-07306-1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Perez-Moreno P, Brambilla E, Thomas R, Soria JC. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res. 2012;18(9):2443–51. https://doi.org/10.1158/1078-0432.CCR-11-2370.
Article
CAS
PubMed
Google Scholar
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, et al. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. Lancet (London, England). 2019;393(10183):1819–1830.
Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gümüş M, Mazières J, et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung Cancer. N Engl J Med. 2018;379(21):2040–51. https://doi.org/10.1056/NEJMoa1810865.
Article
CAS
PubMed
Google Scholar
Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–54. https://doi.org/10.1038/nature25183.
Article
CAS
PubMed
Google Scholar
Zhao W, Choi YL, Song JY, Zhu Y, Xu Q, Zhang F, et al. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare. Lung Cancer. 2016;94:22–7. https://doi.org/10.1016/j.lungcan.2016.01.011.
Article
PubMed
Google Scholar
Pan Y, Wang R, Ye T, Li C, Hu H, Yu Y, et al. Comprehensive analysis of oncogenic mutations in lung squamous cell carcinoma with minor glandular component. Chest. 2014;145(3):473–9. https://doi.org/10.1378/chest.12-2679.
Article
PubMed
Google Scholar
Filipits M. New developments in the treatment of squamous cell lung cancer. Curr Opin Oncol. 2014;26(2):152–8. https://doi.org/10.1097/CCO.0000000000000049.
Article
CAS
PubMed
Google Scholar
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung Cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11(1):39–51. https://doi.org/10.1016/j.jtho.2015.09.009.
Article
Google Scholar
Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. J Exp Clin Cancer Res. 2000;19(4):477–81.
CAS
PubMed
Google Scholar
Wu H, Wang Q, Liu Q, Zhang Q, Huang Q, Yu Z. The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer. Clin Lab. 2020;66(3).
Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911–7. https://doi.org/10.1139/o59-099.
Article
CAS
PubMed
Google Scholar
Khomtchouk BB, Hennessy JR, Wahlestedt C. shinyheatmap: Ultra fast low memory heatmap web interface for big data genomics. PloS one. 2017;12(5):e0176334.
Article
Google Scholar
Taniguchi M, Okazaki T. The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders. Biochim Biophys Acta. 2014;1841(5):692–703. https://doi.org/10.1016/j.bbalip.2013.12.003.
Article
CAS
PubMed
Google Scholar
Huang H, Tong TT, Yau LF, Chen CY, Mi JN, Wang JR, et al. LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain. BMC Cancer. 2018;18(1):799. https://doi.org/10.1186/s12885-018-4714-x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Marien E, Meister M, Muley T, Fieuws S, Bordel S, Derua R, et al. Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles. Int J Cancer. 2015;137(7):1539–48. https://doi.org/10.1002/ijc.29517.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu Z, Chen H, Zhu Y, Ai J, Li Y, Gu W, et al. Global lipidomics reveals two plasma lipids as novel biomarkers for the detection of squamous cell lung cancer: a pilot study. Oncol Lett. 2018;16(1):761–8. https://doi.org/10.3892/ol.2018.8740.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goto T, Terada N, Inoue T, Kobayashi T, Nakayama K, Okada Y, et al. Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer. Prostate. 2015;75(16):1821–30. https://doi.org/10.1002/pros.23088.
Article
CAS
PubMed
Google Scholar
Kawase A, Yoshida J, Miyaoka E, Asamura H, Fujii Y, Nakanishi Y, et al. Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2013;8(5):606–11. https://doi.org/10.1097/JTO.0b013e31828632b8.
Article
Google Scholar
Jin C, Yuan P. Implications of lipid droplets in lung cancer: associations with drug resistance. Oncol Lett. 2020;20(3):2091–104. https://doi.org/10.3892/ol.2020.11769.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bianchi C, Meregalli C, Bombelli S, Di Stefano V, Salerno F, Torsello B, et al. The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation. Oncotarget. 2017;8(69):113502–15. https://doi.org/10.18632/oncotarget.23056.
Article
PubMed
PubMed Central
Google Scholar
Itoh M, Kitano T, Watanabe M, Kondo T, Yabu T, Taguchi Y, et al. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia. Clin Cancer Res. 2003;9(1):415–23.
CAS
PubMed
Google Scholar
Tafesse FG, Huitema K, Hermansson M, van der Poel S, van den Dikkenberg J, Uphoff A, et al. Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells. J Biol Chem. 2007;282(24):17537–47. https://doi.org/10.1074/jbc.M702423200.
Article
CAS
PubMed
Google Scholar
Lemonnier LA, Dillehay DL, Vespremi MJ, Abrams J, Brody E, Schmelz EM. Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys. 2003;419(2):129–38. https://doi.org/10.1016/j.abb.2003.08.023.
Article
CAS
PubMed
Google Scholar
Barceló-Coblijn G, Martin ML, de Almeida RF, Noguera-Salvà MA, Marcilla-Etxenike A, Guardiola-Serrano F, et al. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy. Proc Natl Acad Sci U S A. 2011;108(49):19569–74. https://doi.org/10.1073/pnas.1115484108.
Article
PubMed
PubMed Central
Google Scholar
Thomson NC, Chaudhuri R, Spears M, Messow CM, Jelinsky S, Miele G, et al. Arachidonic acid metabolites and enzyme transcripts in asthma are altered by cigarette smoking. Allergy. 2014;69(4):527–36. https://doi.org/10.1111/all.12376.
Article
CAS
PubMed
Google Scholar
Rao AM, Hatcher JF, Dempsey RJ. Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection. J Neurochem. 2000;75(6):2528–35. https://doi.org/10.1046/j.1471-4159.2000.0752528.x.
Article
CAS
PubMed
Google Scholar
Mikami H, Kimura O, Yamamoto H, Kikuchi S, Nakamura Y, Ando T, et al. A multicentre clinical validation of AminoIndex Cancer screening (AICS). Sci Rep. 2019;9(1):13831. https://doi.org/10.1038/s41598-019-50304-y.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shimbo K, Kubo S, Harada Y, Oonuki T, Yokokura T, Yoshida H, et al. Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry. Biomed Chromatogr. 2010;24(7):683–91. https://doi.org/10.1002/bmc.1346.
Article
CAS
PubMed
Google Scholar